JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB20039

HRP Anti-Influenza B Virus antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Goat Polyclonal Influenza B Virus antibody - conjugated to HRP. Suitable for ELISA, WB and reacts with Influenza B samples. Cited in 1 publication.

View Alternative Names

Influenza B Virus NP, NP, Nucleocapsid protein, Nucleoprotein, Protein N

Key facts

Host species

Goat

Clonality

Polyclonal

Isotype

IgG

Conjugation

HRP

Excitation/Emission
Carrier free

No

Reacts with

Influenza B

Applications

WB, ELISA

applications

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Influenza B": { "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p>Dilution optimised using Chromogenic detection.</p>" } } }
style
left-column
style
left-column

Properties and storage information

Form
Liquid
Purity
IgG fraction
Purification notes
Purified IgG fraction of antiserum covalently coupled to a highly purified preparation of Horseradish Peroxidase (RZ>3). Care is taken to ensure adequate conjugation while preserving maximum enzyme activity. Free enzyme is removed. Estimated molar HRP: IgG substitution is 2-3.
Storage buffer
Preservative: 0.002% Thimerosal (merthiolate) Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Influenza B virus also known as flu B is an important pathogen in humans. It is part of the Orthomyxoviridae family and consists of a segmented RNA genome. The virus includes various structural proteins such as hemagglutinin (HA) and neuraminidase (NA) which are main surface proteins and matrix proteins. HA has a mass around 75 kDa and is key in virus attachment to host cells. This virus expresses itself mainly in the respiratory tract where it causes infections.
Biological function summary

Influenza B virus plays a significant role in viral infection by mediating cell entry. It is part of a complex life cycle involving binding to sialic acid receptors on host cells through HA causing uptake of the virus. The RNA genome replication and protein synthesis occur in the host cell's nucleus. The release of new virus particles happens through budding facilitated by NA. This virus contributes to the spread of infection among humans impacting healthcare systems.

Pathways

The lifecycle of the Influenza B virus integrates with cellular mechanisms of the host. The replication involves host pathways for RNA transcription and translation. It is related to the activation of immune response pathways including interferon signaling. The virus interacts with cellular proteins such as MxA which is part of the antiviral defense mechanism aimed to hinder viral replication.

Influenza B virus links to seasonal flu epidemics causing respiratory illnesses in populations. It often leads to complications such as bronchitis or pneumonia especially in vulnerable groups. The virus also contributes to exacerbation of chronic conditions like asthma. Hemagglutinin and neuraminidase key proteins of the virus often change through antigenic drift allowing the virus to evade immune detection and complicating vaccine development and effectiveness.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

See full target information Influenza B Virus
style
left-column

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

The Journal of allergy and clinical immunology 139:1575-1582.e8 PubMed28209343

2017

A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis.

Applications

Unspecified application

Species

Unspecified reactive species

Donald Y M Leung,Brett Jepson,Lisa A Beck,Jon M Hanifin,Lynda C Schneider,Amy S Paller,Katherine Monti,Gloria David,Jennifer Canniff,Margarita Gomez Lorenzo,Adriana Weinberg
View all publications
style
left-column
style
left-column
style
right-column

Alternative Products

Primary Antibodies

AB20055

Biotin Anti-Influenza B Virus antibody

  • 0
  • 0

Complementary Products

Secondary Antibodies

AB150113

Goat Anti-Mouse IgG H&L (Alexa Fluor® 488)

  • 5
  • 15
Primary Antibodies

AB252756

HRP Anti-Influenza A virus H1N1 antibody

  • 0
  • 0
Sample Prep & Detection Kits

AB269824

Alexa Fluor® 700 Conjugation Kit (Fast) - Lightning-Link®

  • 0
  • 0
Proteins & Peptides

AB224859

Recombinant Influenza A Influenza A Virus Nucleoprotein (His tag)

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com